| Analysis | Metabolite Name | Measured Value | Units | Acclimatization temperature | Heat exposure |
|---|---|---|---|---|---|
| HILIC POSITIVE ION MODE | Pyridoxamine (PM) | 8930.392 | mV*min | - | group H exposure to 31°C for 3hours |
| HILIC POSITIVE ION MODE | Pyridoxamine (PM) | 9224.919 | mV*min | 30°C | - |
| HILIC POSITIVE ION MODE | Pyridoxamine (PM) | 9469.325833 | mV*min | - | group H exposure to 31°C for 3hours |
| HILIC POSITIVE ION MODE | Pyridoxamine (PM) | 10204.97138 | mV*min | - | group H exposure to 31°C for 3hours |
| HILIC POSITIVE ION MODE | Pyridoxamine (PM) | 10235.58324 | mV*min | - | group L exposure to 31°C for 3hours |
| HILIC POSITIVE ION MODE | Pyridoxamine (PM) | 10944.53223 | mV*min | - | - |
| HILIC POSITIVE ION MODE | Pyridoxamine (PM) | 10979.65094 | mV*min | - | group H exposure to 31°C for 3hours |
| HILIC POSITIVE ION MODE | Pyridoxamine (PM) | 11247.06824 | mV*min | - | group L exposure to 31°C for 3hours |
| HILIC POSITIVE ION MODE | Pyridoxamine (PM) | 11295.38824 | mV*min | - | group L exposure to 31°C for 3hours |
| HILIC POSITIVE ION MODE | Pyridoxamine (PM) | 12013.29539 | mV*min | - | group L exposure to 31°C for 3hours |
| HILIC POSITIVE ION MODE | Pyridoxamine (PM) | 12035.42333 | mV*min | 30°C | - |
| HILIC POSITIVE ION MODE | Pyridoxamine (PM) | 12428.01222 | mV*min | 10°C | - |
| HILIC POSITIVE ION MODE | Pyridoxamine (PM) | 12576.74537 | mV*min | - | group L exposure to 31°C for 3hours |
| HILIC POSITIVE ION MODE | Pyridoxamine (PM) | 12692.91171 | mV*min | 30°C | - |
| HILIC POSITIVE ION MODE | Pyridoxamine (PM) | 12717.66818 | mV*min | - | - |
| HILIC POSITIVE ION MODE | Pyridoxamine (PM) | 12804.99194 | mV*min | - | group H exposure to 31°C for 3hours |
| HILIC POSITIVE ION MODE | Pyridoxamine (PM) | 12812.02975 | mV*min | 30°C | - |
| HILIC POSITIVE ION MODE | Pyridoxamine (PM) | 13064.38555 | mV*min | 30°C | - |
| HILIC POSITIVE ION MODE | Pyridoxamine (PM) | 13384.46622 | mV*min | 30°C | - |
| HILIC POSITIVE ION MODE | Pyridoxamine (PM) | 13774.29553 | mV*min | - | group L exposure to 31°C for 3hours |
| HILIC POSITIVE ION MODE | Pyridoxamine (PM) | 13996.69289 | mV*min | - | group L exposure to 31°C for 3hours |
| HILIC POSITIVE ION MODE | Pyridoxamine (PM) | 14002.70519 | mV*min | 30°C | - |
| HILIC POSITIVE ION MODE | Pyridoxamine (PM) | 14063.04 | mV*min | 10°C | - |
| HILIC POSITIVE ION MODE | Pyridoxamine (PM) | 14079.52105 | mV*min | - | - |
| HILIC POSITIVE ION MODE | Pyridoxamine (PM) | 14243.47467 | mV*min | - | group L exposure to 31°C for 3hours |
| HILIC POSITIVE ION MODE | Pyridoxamine (PM) | 14368.113 | mV*min | 10°C | - |
| HILIC POSITIVE ION MODE | Pyridoxamine (PM) | 14781.2273 | mV*min | 30°C | - |
| HILIC POSITIVE ION MODE | Pyridoxamine (PM) | 14785.70992 | mV*min | 10°C | - |
| HILIC POSITIVE ION MODE | Pyridoxamine (PM) | 15030.21616 | mV*min | - | group H exposure to 31°C for 3hours |
| HILIC POSITIVE ION MODE | Pyridoxamine (PM) | 15115.37781 | mV*min | - | - |
| HILIC POSITIVE ION MODE | Pyridoxamine (PM) | 15352.28933 | mV*min | - | - |
| HILIC POSITIVE ION MODE | Pyridoxamine (PM) | 15842.57043 | mV*min | - | group L exposure to 31°C for 3hours |
| HILIC POSITIVE ION MODE | Pyridoxamine (PM) | 16042.3198 | mV*min | - | group H exposure to 31°C for 3hours |
| HILIC POSITIVE ION MODE | Pyridoxamine (PM) | 16064.06833 | mV*min | 30°C | - |
| HILIC POSITIVE ION MODE | Pyridoxamine (PM) | 16098.39429 | mV*min | 10°C | - |
| HILIC POSITIVE ION MODE | Pyridoxamine (PM) | 16225.445 | mV*min | 10°C | - |
| HILIC POSITIVE ION MODE | Pyridoxamine (PM) | 16254.90335 | mV*min | - | - |
| HILIC POSITIVE ION MODE | Pyridoxamine (PM) | 17298.45444 | mV*min | 10°C | - |
| HILIC POSITIVE ION MODE | Pyridoxamine (PM) | 17497.64588 | mV*min | - | group H exposure to 31°C for 3hours |
| HILIC POSITIVE ION MODE | Pyridoxamine (PM) | 17909.52737 | mV*min | 10°C | - |
| HILIC POSITIVE ION MODE | Pyridoxamine (PM) | 19047.72358 | mV*min | 10°C | - |
| HILIC POSITIVE ION MODE | Pyridoxamine (PM) | 19155.69845 | mV*min | - | group H exposure to 31°C for 3hours |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|